Atibuclimab |
カタログ番号GC66359 |
Atibuclimab は、CD14 に対するキメラモノクローナル抗体であり、マウスの可変およびヒト IgG4 Fc 領域で構成されています。 Atibuclimab は、筋萎縮性側索硬化症の研究に使用できます。 Atibuclimab は、抗炎症性サイトカインである可溶性 TNF 受容体 I 型および IL-1 受容体アンタゴニストの放出を遅らせるだけでありながら、LPS 誘発性の症状を軽減し、LPS 誘発性の炎症誘発性サイトカインの放出を強力に阻害します。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2417175-94-9
Sample solution is provided at 25 µL, 10mM.
Atibuclimab, is a chimeric monoclonal antibody directed against CD14 and is composed of murine variable and human IgG4 Fc regions. Atibuclimab can be used for the research of amyotrophic lateral sclerosis[1]. Atibuclimab attenuates LPS-induced symptoms and strongly inhibits LPS-induced proinflammatory cytokine release, while only delaying the release of the anti-inflammatory cytokines soluble TNF receptor type I and IL-1 receptor antagonist[2].
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *